ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Everest Group Ltd

Everest Group Ltd (EG)

400.00
1.92
(0.48%)
At close: July 18 4:00PM
400.00
0.00
( 0.00% )
After Hours: 5:35PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
400.00
Bid
-
Ask
-
Volume
224,430
398.1275 Day's Range 406.395
343.36 52 Week Range 417.92
Market Cap
Previous Close
398.08
Open
398.80
Last Trade
8
@
400
Last Trade Time
17:03:09
Financial Volume
$ 90,274,847
VWAP
402.2406
Average Volume (3m)
264,444
Shares Outstanding
43,458,245
Dividend Yield
1.81%
PE Ratio
6.91
Earnings Per Share (EPS)
57.92
Revenue
14.59B
Net Profit
2.52B

About Everest Group Ltd

Everest Re Group Ltd is engaged in providing insurance services in the U.S., Bermuda, and international markets. It operates in two segments: Reinsurance and Insurance. The Reinsurance operation writes worldwide property and casualty reinsurance and specialty lines of business, on both a treaty and ... Everest Re Group Ltd is engaged in providing insurance services in the U.S., Bermuda, and international markets. It operates in two segments: Reinsurance and Insurance. The Reinsurance operation writes worldwide property and casualty reinsurance and specialty lines of business, on both a treaty and facultative basis, through reinsurance brokers, as well as directly with ceding companies. The Insurance operation writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Bermuda, Canada, Europe, and South America. Show more

Sector
Fire, Marine, Casualty Ins
Industry
Fire, Marine, Casualty Ins
Headquarters
Hamilton, Bmu
Founded
1970
Everest Group Ltd is listed in the Fire, Marine, Casualty Ins sector of the New York Stock Exchange with ticker EG. The last closing price for Everest was $398.08. Over the last year, Everest shares have traded in a share price range of $ 343.36 to $ 417.92.

Everest currently has 43,458,245 shares outstanding. The market capitalization of Everest is $17.30 billion. Everest has a price to earnings ratio (PE ratio) of 6.91.

EG Latest News

Everest Announces Key Claims Leadership Appointments

Andrew McBride named Group Chief Claims Officer Lope Garcia joins Everest Reinsurance as Chief Claims Officer Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class...

Everest Group to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 1, 2024

Everest Group, Ltd. (“Everest”) (NYSE: EG) will hold its second quarter 2024 earnings conference call on Thursday, August 1, 2024, beginning at 8:00 am Eastern Time. Dial in details can be...

Everest Group Increases Quarterly Dividend to $2.00

Everest Group, Ltd. announced that its Board of Directors declared an increase in the regular quarterly dividend from $1.75 to $2.00 per common share. This dividend will be payable on or before...

Everest Reports First Quarter 2024 Results

Net Income of $733 million and Operating Income of $709 million TSR1 of 18.1%; 20.6% Net Income ROE and 20.0% Operating Income ROE 88.8% Combined Ratio Resulting in Record Underwriting Income of...

Everest Expands Jim Williamson’s Role to Lead Company’s Global Underwriting Businesses

Mike Karmilowicz Appointed to Chairman, Everest Global Insurance Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance...

Everest Group to Hold First Quarter 2024 Earnings Conference Call on Tuesday, April 30, 2024

Everest Group, Ltd. (“Everest”) (NYSE: EG) will hold its first quarter 2024 earnings conference call on Tuesday, April 30, 2024, beginning at 8:00 am Eastern Time. Dial in details can be obtained...

Everest Group Announces Dividend

Everest Group, Ltd. announced that its Board of Directors declared a dividend of $1.75 per common share payable on or before March 27, 2024 to all shareholders of record as of March 19, 2024...

 Everest Announces Leadership Promotions in Reinsurance Division

 Jill Beggs, Head of North America Treaty Reinsurance, Appointed to Reinsurance Division Chief Operating Officer Jiten Voralia, Head of Treaty Casualty & Surety, Named Reinsurance Head of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
121.015.54368189134378.99406.395375.39275465392.32682236CS
421.795.76134951482378.21406.395358.63292338379.22191095CS
1234.529.44511327569365.48406.395351.52264444379.18260444CS
26369.89010989011364406.395343.76316770375.78884735CS
5242.411.8568232662357.6417.92343.36331928377.23493878CS
15651.214.6788990826348.8417.92343.36329737376.93525676CS
26051.214.6788990826348.8417.92343.36329737376.93525676CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 4.36
(65.78%)
2.21M
NVOSNovo Integrated Sciences Inc
$ 0.8094
(34.38%)
6.7M
DRUGBright Minds Biosciences Inc
$ 1.2698
(16.50%)
344.11k
TCTuanChe Ltd
$ 1.79
(15.48%)
40.83k
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2801
(13.86%)
383.5k
KITTNauticus Robotics Inc
$ 0.0999
(-22.50%)
8.67M
ZCMDZhongchao Inc
$ 1.12
(-15.79%)
358
SCHLScholastic Corporation
$ 32.59
(-10.86%)
9.3k
PLUGPlug Power Inc
$ 2.62
(-10.27%)
5.03M
GDTCCytoMed Therapeutics Ltd
$ 2.06
(-10.05%)
4.13k
KITTNauticus Robotics Inc
$ 0.0999
(-22.50%)
8.67M
NVOSNovo Integrated Sciences Inc
$ 0.8094
(34.38%)
6.7M
NVDANVIDIA Corporation
$ 121.77
(0.56%)
5.79M
ONCOOnconetix Inc
$ 0.204
(-6.55%)
5.56M
PLUGPlug Power Inc
$ 2.62
(-10.27%)
5.03M

Discussion

View Full Feed
Mark Mark 3 minutes ago
$SERV hit 4.44 high in A/Hs, nice call.
SERV
Pierrocks Pierrocks 4 minutes ago
I Tarzan you Jane. -Pier
TSOI
gdl gdl 4 minutes ago
6-day event on Nasdaq ONLY. The 3 indices are out of sync. Let's see if that holds. On the political front obviously Trump and his running mate is giving them pause on their party choice to win the election. Add the growing storm and pressure for Biden to exit. that is now likely. he has no s
jay_tee jay_tee 4 minutes ago
I agree. No one gets paid to bash a no bidder especially one that sits on the EM. 99% of people who post do it just because of entertainment! lol 1% actually provide logical, factual, and informative posts. I’m here because of a little logic but mostly entertainment! Lol
RNVA
jsc52033 jsc52033 5 minutes ago
question for the board
DOwn broke down and began to fill the along naked candel, Spy gapped down, Gold looks to be form a cup wwith the beginning of a handle.
Can Spy get back up to test that high for a place short?
SPY
novascotiaSTS novascotiaSTS 5 minutes ago
You don’t need to worry, European investors won’t receive any payments according to AZ because you need to be a US Participating Member

:-)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171122810
COOP
mike93433 mike93433 6 minutes ago
And it shows in the share price. Hopefully the Investor Talk next week reveals some good news: https://investornews.com/events/investortalk-with-ian-clifford-from-fuelpositive-corporation-tsxv-nhhh-otcqb-nhhhf/
NHHHF
DesktopDR DesktopDR 6 minutes ago
Why did the website address change?
https://www.voip-pal.com was being used until recently
VPLM
Duma Duma 7 minutes ago
Sorry for the shortcut. LOY=low of yesterday. Could have used YL for yesterday low.
NorthPeak22 NorthPeak22 7 minutes ago
Sky Sports Reports Celtic Have Signed Kasper Schmeichel

https://www.inflation.us/content/sky-sports-reports-celtic-have-signed-kasper-schmeichel

Celtic plc (LSE: CCP) or CLTFF has officially signed veteran goalkeeper Kasper Schmeichel to a one-year deal according to Sky
CLTFF
StockRocket StockRocket 7 minutes ago
lmfao 2010-14 yrs ago...NOT sticking up for him...but giving him a chance at these prices to get job done
GMZP
StockRocket StockRocket 7 minutes ago
lmfao 2010-14 yrs ago...NOT sticking up for him...but giving him a chance at these prices to get job done
GMZP
IB_ IB_ 8 minutes ago
LoL LoL, you do realize that your commentary contributes nothing to the board, right ???????????

Seriously, is this the job you always dreamed of ???????? What may I ask is your compensation, $0.05 Per Post ??????????????

IB_🤴🏻
ELTP
Patient Ninja Patient Ninja 8 minutes ago
Ninja has never seen GAHC this active in any price band as this year. Whatever makes it break out soon will send it rocketing to the sky. I'm tipping sometime in the next few months.
GAHC
Bubae Bubae 8 minutes ago
You know what I find interesting is that this Markowski character and Shawn Leon teamed up to super spin projections and none of you long time pumpers are promoting the story line. Those podcasts were so badly done that even you all aren't taking the bait. What they are doing is straight up stock pr
GRST
OMOLIVES OMOLIVES 8 minutes ago
Man...it's killing you...lol. I do get your point though. It seems opposite to what they set out to do. Less is more...and this looks like a confusing run around.
BDEZ BDEZ 9 minutes ago
Add “be able to do a push-up”!
Tomorrowneverknows Tomorrowneverknows 9 minutes ago
Sweeeet
HIRU
BLACKBIRDSR-71 BLACKBIRDSR-71 10 minutes ago
Going BigTime$$$$$$
RNVA
Swampy83 Swampy83 10 minutes ago
Today must be bashing day... always the same 3 clowns.
Shocker!
SMCE
dailyinvestingadvice dailyinvestingadvice 10 minutes ago
Congrats on the gains. I'm holding a few million shares in the Roth and some more I've been accumulating sub penny. I am green again on position after today's move because I have kept my average super duper low (originally bought around .02) and have even averaged down. Some are just so pessimistic
WNFT
Doc logic Doc logic 10 minutes ago
dmb2,

FDA wants all the attention on them and their approval process allows for more subjectivity which creates a target for attempted influence. The UK and EU require more upfront spending and preparation for manufacturing roll out which helps weed out anyone not serious about getti
NWBO
Involuntary-Recluse Involuntary-Recluse 10 minutes ago
R.I.P Bob Newhart and Lou Dobbs 😇😇
Thanks for all the memories...
georgejjl georgejjl 11 minutes ago
Abe,

I am sorry but the Phase2b/3 Alzheimer’s disease treatment trial using blarcamesine did NOT include any patients in Spain.

It included patients in and from Australia, the UK, Canada, the Netherlands and Germany.

There could however have been multiple
AVXL